A company called Synchron is trying to make a special device that can help people with brain problems like Parkinson's and epilepsy. They want to compete with another company called Neuralink, which is also making a similar device. Both companies are working hard to make their devices safe and effective for people who need them. Read from source...

- The article title is misleading and clickbait, as it implies that Synchron is a direct rival to Neuralink, while in reality, both companies are working on different approaches and timelines for brain-computer interfaces.
- The article does not provide any evidence or data to support the claim that Synchron's plans to treat Parkinson's and epilepsy are broadening horizons, nor how they compare to Neuralink's goals and achievements.
- The article mentions a malfunction in Neuralink's system, but does not mention any details or context about the cause, severity, or resolution of the issue. It also contrasts this with Synchron's announcement without acknowledging that both companies are still in early stages of development and testing.
- The article cites Jim Cramer as an authority on the topic, but does not disclose his affiliation or potential bias towards certain stocks or companies.